Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
28-Feb-23 | Interim | 0.03 | (1.81) | 0.36p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Aug-20 | n/a | (0.33) | (1.51)p | n/a | n/a | n/a | n/a | 0.0% |
31-Aug-21 | n/a | (3.33) | (0.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Aug-22 | 0.03 | (5.99) | (1.18)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 0.93p |
Change Today | -0.025p |
% Change | -2.63 % |
52 Week High | 2.80 |
52 Week Low | 0.50 |
Volume | 1,833,693 |
Shares Issued | 602.25m |
Market Cap | £5.57m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:27 | 2,475 @ 0.90p |
16:27 | 125,000 @ 0.94p |
16:25 | 73 @ 0.95p |
16:13 | 1,664 @ 0.90p |
16:09 | 13 @ 0.95p |
CEO | Anna Chokina |
CFO | Bruna Nikolla |
You are here: research